Publication | Closed Access
MV-626, a potent and selective inhibitor of ENPP1 enhances STING activation and augments T-cell mediated anti-tumor activity in vivo
20
Citations
0
References
2018
Year
Unknown Venue
Cancer ImmunosurveillanceMedicineImmunologySelective InhibitorAugments T-cellAnti-cancer AgentAnti-tumor ActivityImmunotherapyCell Biology
No additional data available for this publication yet. Check back later!